Effect of the Aldose Reductase Inhibitor Tolrestat on Nerve Conduction Velocity, NA/K ATPase Activity, and Polyols in Red Blood Cells, Sciatic Nerve, Kidney Cortex, and Kidney Medulla of Diabetic Rats

This publication has 34 references indexed in Scilit:

• The Aetiology of Diabetic Neuropathy: the Combined Roles of Metabolic and Vascular Defects
  Diabetic Medicine, 1995
• Aldose reductase inhibitors: An approach to the treatment of diabetic nerve damage
  Diabetes/Metabolism Research and Reviews, 1993
• Effect of hyperglycemia and the aldose reductase inhibitor tolrestat on sural nerve biochemistry and morphometry in advanced diabetic peripheral polyneuropathy
  Journal of Diabetes and its Complications, 1993
• Aldose Reductase Inhibitors and the Complications of Diabetes Mellitus
  Diabetic Medicine, 1993
• A multicentre trial of the aldose-reductase inhibitor, tolrestat, in patients with symptomatic diabetic neuropathy
  Diabetologia, 1990
• Regeneration and Repair of Myelinated Fibers in Sural-Nerve Biopsy Specimens from Patients with Diabetic Neuropathy Treated with Sorbinil
  New England Journal of Medicine, 1988
• Action of sorbinil in diabetic peripheral nerve. Relationship of polyol (sorbitol) pathway inhibition to a myo-inositol-mediated defect in sodium-potassium ATPase activity
  Diabetes, 1984
• Prevention and reversal of defective axonal transport and motor nerve conduction velocity in rats with experimental diabetes by treatment with the aldose reductase inhibitor Sorbinil
  Diabetes, 1984
• Aldose Reductase Inhibition Improves Nerve Conduction Velocity in Diabetic Patients
  New England Journal of Medicine, 1983
• The effect of aldose reductase inhibition on motor nerve conduction velocity in diabetic rats
  Diabetes, 1982